HIF1-α, NF-κB and GM-CSF expression levels in tumour were higher, and CD33 + MDSCs showed an increased retention in the tumour stroma, whereas CD8 + lymphocyte numbers in tumour epithelium were markedly reduced after bevacizumab treatment (Fig. 6f). The gene discussed is CSF2; the disease is neoplasm.